Revolution Medicines Stock

Revolution Medicines ROA 2024

Revolution Medicines ROA

-0.21

Ticker

RVMD

ISIN

US76155X1000

WKN

A2PYWG

In 2024, Revolution Medicines's return on assets (ROA) was -0.21, a -30.91% increase from the -0.31 ROA in the previous year.

Revolution Medicines Aktienanalyse

What does Revolution Medicines do?

Revolution Medicines Inc is a biotechnology company specializing in the development of cancer medications. It was founded in 2014 in Redwood City, California. The company has received significant investment amounts in recent years and is focused on researching and developing personalized cancer therapies that act on a molecular level. They employ a new method called "in-situ imaging" for faster and more precise identification of treatment options. Revolution Medicines is divided into various areas including research and development of new drugs, collaboration with external partners, and conducting their own testing procedures. Their products include a variety of tailored cancer therapies, with RMC-4630 being one of their most promising therapies for advanced breast cancer. They have more products in development and aim to expand their development opportunities through partnerships with other companies in the cancer research field. This company aims to revolutionize cancer research by developing targeted therapies customized to meet individual patient needs, utilizing innovative methods and technologies. However, they face challenges in understanding and treating the complexity of molecular processes in cancer cells, as well as competition in the field. Overall, Revolution Medicines is a biotechnology company focused on shaping the future of cancer research. Revolution Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Revolution Medicines's Return on Assets (ROA)

Revolution Medicines's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Revolution Medicines's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Revolution Medicines's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Revolution Medicines’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Revolution Medicines stock

What is the Return on Assets (ROA) of Revolution Medicines this year?

The Return on Assets (ROA) of Revolution Medicines is -0.21 undefined this year.

What was the ROA of Revolution Medicines compared to the previous year?

The ROA of Revolution Medicines has increased by -30.91% compared to the previous year.

What consequences do high ROA have for investors of Revolution Medicines?

A high ROA is advantageous for investors of Revolution Medicines, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Revolution Medicines?

A low ROA can be unfavorable for investors of Revolution Medicines as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Revolution Medicines affect the company?

An increase in ROA of Revolution Medicines can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Revolution Medicines impact the company?

A reduction in the ROA of Revolution Medicines can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Revolution Medicines?

Some factors that can influence the ROA of Revolution Medicines include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Revolution Medicines important for investors?

The ROA of Revolution Medicines is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Revolution Medicines take to improve ROA?

To improve ROA, Revolution Medicines can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Revolution Medicines pay?

Over the past 12 months, Revolution Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revolution Medicines is expected to pay a dividend of 0 USD.

What is the dividend yield of Revolution Medicines?

The current dividend yield of Revolution Medicines is .

When does Revolution Medicines pay dividends?

Revolution Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revolution Medicines?

Revolution Medicines paid dividends every year for the past 0 years.

What is the dividend of Revolution Medicines?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revolution Medicines located?

Revolution Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revolution Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revolution Medicines from 12/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/1/2024.

When did Revolution Medicines pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Revolution Medicines in the year 2023?

In the year 2023, Revolution Medicines distributed 0 USD as dividends.

In which currency does Revolution Medicines pay out the dividend?

The dividends of Revolution Medicines are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revolution Medicines

Our stock analysis for Revolution Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revolution Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.